Inhibrx News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Inhibrx. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Inhibrx Today - Breaking & Trending Today
Shares of Inhibrx, Inc. (NASDAQ:INBX – Get Free Report) saw an uptick in trading volume on Monday . 1,719,541 shares were traded during trading, an increase of 139% from the previous session’s volume of 718,804 shares.The stock last traded at $34.92 and had previously closed at $34.97. Analyst Upgrades and Downgrades INBX has been the […] ....
JMP Securities restated their market perform rating on shares of Inhibrx (NASDAQ:INBX – Free Report) in a research report released on Tuesday, MarketBeat.com reports. Inhibrx Stock Up 0.3 % Shares of INBX stock traded up $0.10 during trading hours on Tuesday, reaching $37.60. The company had a trading volume of 632,344 shares, compared to its […] ....
Inhibrx (NASDAQ:INBX – Get Free Report) was downgraded by stock analysts at Lifesci Capital from an “outperform” rating to a “market perform” rating in a research note issued on Tuesday, PriceTargets.com reports. Separately, JMP Securities reissued a “market perform” rating on shares of Inhibrx in a research note on Tuesday. Get Our Latest Report on […] ....
General Electric tumbles after first-quarter earnings guidance misses estimates, while shares of United Airlines rise after the carrier’s expectations for. ....
The acquisition is the latest in a string of small- and mid-sized deals as Sanofi looks to double down on innovative medicines and reduce its reliance on the blockbuster asthma medicine Dupixent. ....